Adhesive Capsulitis, Frozen Shoulder
Conditions
Keywords
Hyaluronic Acid, Ultrasound-Guided Injection, Rehabilitation, SPADI
Brief summary
This randomized controlled trial evaluates the clinical efficacy of ultrasound-guided intra-articular hyaluronic acid injection combined with rehabilitation in patients with adhesive capsulitis (frozen shoulder). Participants were randomly assigned to either an injection plus rehabilitation group or a rehabilitation-only group. The injection group received ultrasound-guided intra-articular hyaluronic acid once weekly for three weeks, along with a standardized rehabilitation program for six weeks. The control group received the same rehabilitation program without injection. Clinical outcomes were assessed at multiple time points, including baseline, 4, 6, 8, and 12 weeks. The primary outcome was the change in the Shoulder Pain and Disability Index (SPADI) total score. Secondary outcomes included SPADI pain and disability subscales, as well as shoulder range of motion. The trial was registered retrospectively at ClinicalTrials.gov (NCT07570095) after study completion due to administrative oversight. The study was conducted in accordance with the protocol approved by the Tri-Service General Hospital Institutional Review Board (approval no. C202205160) prior to enrollment. The IRB-approved protocol specified the eligibility criteria and outcome measures reported in this record; discrepancies in the initial registry entry have been corrected in this amendment.
Detailed description
Adhesive capsulitis is a common musculoskeletal disorder characterized by progressive pain and restricted range of motion of the shoulder joint, leading to significant functional impairment. Although rehabilitation remains the cornerstone of treatment, the additional benefit of intra-articular hyaluronic acid injection remains controversial. This randomized controlled trial aimed to evaluate the clinical efficacy of ultrasound-guided intra-articular injection of non-cross-linked hyaluronic acid combined with a structured rehabilitation program in patients with adhesive capsulitis. Participants were randomly assigned to two groups: an injection plus rehabilitation group and a rehabilitation-only group. The injection group received ultrasound-guided intra-articular hyaluronic acid injections once weekly for three consecutive weeks. Both groups underwent a standardized rehabilitation program twice weekly for six weeks, including range of motion exercises, stretching, and strengthening under the supervision of a physical therapist. Clinical outcomes were assessed at multiple time points, including baseline, 4, 6, 8, and 12 weeks. The primary outcome measure was the change in the Shoulder Pain and Disability Index (SPADI) total score over time. Secondary outcomes included SPADI pain and disability subscales, as well as shoulder external rotation range of motion. The trial was registered retrospectively at ClinicalTrials.gov (NCT07570095) after study completion due to administrative oversight. The study was conducted in accordance with the protocol approved by the Tri-Service General Hospital Institutional Review Board (approval no. C202205160) prior to enrollment. The IRB-approved protocol specified the eligibility criteria and outcome measures reported in this record; discrepancies in the initial registry entry have been corrected in this amendment.
Interventions
Non-cross-linked hyaluronic acid (10 mg/mL) administered via ultrasound-guided intra-articular injection into the affected shoulder joint once weekly for 3 weeks.
Supervised physical therapy program including joint mobilization, stretching, and strengthening exercises, conducted twice weekly for 6 weeks.
Sponsors
Study design
Intervention model description
Randomized
Eligibility
Inclusion criteria
* Adults aged 40 to 70 years. * Clinical diagnosis of frozen-phase primary adhesive capsulitis characterized by predominant stiffness as the chief complaint, with symptom duration of at least 3 months, minimal resting pain, and absence of nocturnal pain. * Limitation of both active and passive shoulder range of motion, particularly in external rotation. * Ability to understand the study procedures and provide informed consent.
Exclusion criteria
* Prior shoulder surgery or fracture on the affected side. * Rotator cuff tear confirmed by imaging. * Glenohumeral osteoarthritis or inflammatory joint disease. * Neurological disorders affecting shoulder function. * Previous intra-articular injection within the past 3 months. * Contraindications to hyaluronic acid injection.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Shoulder Pain and Disability Index (SPADI) Total Score | Baseline, 4 weeks, 6 weeks, 8 weeks, and 12 weeks | The SPADI is a validated questionnaire assessing shoulder pain and functional disability, with total scores ranging from 0 to 100. Higher scores indicate greater impairment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| SPADI Item - Wearing a Pullover Shirt | Baseline, 4, 6, 8, and 12 weeks | Item-level SPADI score for wearing a pullover shirt (requires combined abduction and external rotation), rated 0-10 (0=no difficulty, 10=worst difficulty). |
| SPADI Item - Putting on Pants or Shorts | Time Frame: Baseline, 4, 6, 8, and 12 weeks | Item-level SPADI score for putting on pants or shorts (requires internal rotation and extension), rated 0-10. |
| SPADI Item - Pain on Arm Traction | Time Frame: Baseline, 4, 6, 8, and 12 weeks | Item-level SPADI pain score during arm traction of the affected side (reflects capsular tension), rated 0-10. |
| Shoulder Range of Motion | Baseline, 4, 6, 8, and 12 weeks | Active and passive range of motion of the shoulder (flexion, abduction, external rotation) measured by gravity goniometer by a blinded assessor. |
Countries
Taiwan